Sydney, Australia, 19 October 2022: Imugene Limited (ASX: IMU), a clinical stage immuno-oncology company advises that the attached notice of expiry of IMUOC options letter was sent to all holders of IMUOC listed options (Options) which are exercisable at $0.054 each on or before 5:00 pm AEDT on Wednesday, 30 November 2022 (Expiry Date).
Official quotation of the Options will cease at close of trading on 24 November 2022, being four business days before the Expiry Date. Holders of the
Options can exercise all or part of their Options prior to the Expiry Date. Please find attached the sample “notice of exercise of options” for further instructions.
IMU Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)